FDA-approved kinase inhibitors in preclinical and clinical trials for neurological disorders
A Lui, J Vanleuven, D Perekopskiy, D Liu, D Xu… - Pharmaceuticals, 2022 - mdpi.com
Cancers and neurological disorders are two major types of diseases. We previously
developed a new concept termed “Aberrant Cell Cycle Diseases”(ACCD), revealing that …
developed a new concept termed “Aberrant Cell Cycle Diseases”(ACCD), revealing that …